Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2024 Aug 6;14:1469700. doi: 10.3389/fonc.2024.1469700

Retraction: MiR-1236-3p inhibits the proliferation, invasion, and migration of colon cancer cells and hinders epithelial-mesenchymal transition by targeting DCLK3

Frontiers Editorial Office*
PMCID: PMC11338272  PMID: 39169939

The journal retracts the September 3rd 2021 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. Images presented in this article were subsequently also identified in publications from unrelated author groups. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and agree to retract the article. This communication has been recorded by the publisher.

Frontiers would like to thank Dr Sholto David for contacting the journal regarding the published article, the concerns regarding which were also documented on PubPeer.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES